Cargando…

High proportion of anergic B cells in the bone marrow defined phenotypically by CD21(−/low)/CD38- expression predicts poor survival in diffuse large B cell lymphoma

BACKGROUND: Diffuse large B cell lymphoma (DLBCL) is the commonest lymphoma that is highly aggressive where one-third of the patients relapse despite effective treatment. Interaction between the lymphoma cells and the non-clonal immune cells within the bone marrow microenvironment is thought to play...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rijal, Sewa, Kok, Johanna, Coombes, Caitlin, Smyth, Lillian, Hourigan, Jayde, Jain, Sanjiv, Talaulikar, Dipti
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641859/ https://www.ncbi.nlm.nih.gov/pubmed/33143694 http://dx.doi.org/10.1186/s12885-020-07525-6

Ejemplares similares

Cd5 Maintains Tolerance in Anergic B Cells
por: Hippen, Keli L., et al.
Publicado: (2000)

Genomic profiling of CD20 negative diffuse large B cell lymphoma identifies targetable mutations: A case report
por: Maqbool, M. Gohar, et al.
Publicado: (2020)

Resting and anergic B cells are defective in CD28-dependent costimulation of naive CD4+ T cells
Publicado: (1994)

Low-Level Expression of CD138 Marks Naturally Arising Anergic B Cells
por: Lee, Sujin, et al.
Publicado: (2022)

Regulation of T cell and monocyte activation by human anergic/suppressive CD4 CD25 T cells
por: Taams, LS, et al.
Publicado: (2002)

Memory T cells are anergic to the superantigen staphylococcal enterotoxin B
Publicado: (1992)

Anergic Stupor
por: Dewar, Thomas W.
Publicado: (1884)

The Induction and Maintenance of Transplant Tolerance Engages Both Regulatory and Anergic CD4(+) T cells
por: Besançon, Alix, et al.
Publicado: (2017)

CD4(+)CD25(+ )T regulatory cells from FIV(+ )cats induce a unique anergic profile in CD8(+ )lymphocyte targets
por: Fogle, Jonathan E, et al.
Publicado: (2010)

The signalling signature downstream of the notch receptor in CD4(+)CD25(high )regulatory T cells in RA defines anergic cells: insight into resistance to anti-tumour necrosis factor therapies
por: Buch, MH, et al.
Publicado: (2005)

Combinatorial immunotherapeutic approaches to restore the function of anergic tumor-reactive cytotoxic CD8(+) T cells
por: Redmond, William L., et al.
Publicado: (2016)

Induction of anergic or regulatory tumor-specific CD4(+) T cells in the tumor-draining lymph node
por: Alonso, Ruby, et al.
Publicado: (2018)

Increase in TGF-β Secreting CD4(+)CD25(+) FOXP3(+) T Regulatory Cells in Anergic Lepromatous Leprosy Patients
por: Saini, Chaman, et al.
Publicado: (2014)

CD34 and CD38 are prognostic biomarkers for acute B lymphoblastic leukemia
por: Jiang, Zhiwu, et al.
Publicado: (2016)

Ligation of CD38 suppresses human B lymphopoiesis
Publicado: (1995)

Repertoire analysis of anergic B cells from patients with systemic lupus erythematosus
por: Longo, NS, et al.
Publicado: (2003)

Therapeutic implications of the anergic/postactivated status of B cells in systemic lupus erythematosus
por: Dörner, Thomas, et al.
Publicado: (2020)

CD27(-)CD38(low)CD21(low) B-Cells Are Increased in Axial Spondyloarthritis
por: Wilbrink, Rick, et al.
Publicado: (2021)

Dynamic changes of the proportion of HLA-DR and CD38 coexpression subsets on T lymphocytes during IFN-based chronic hepatitis B treatment
por: Lin, Yanjie, et al.
Publicado: (2023)

Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells
Publicado: (1996)

Decrease in Proportion of CD19(+)CD24(hi)CD27(+) B Cells and Impairment of Their Suppressive Function in Graves’ Disease
por: Zha, Bingbing, et al.
Publicado: (2012)

CD19(+)CD24(hi)CD38(hi) B Cell Dysfunction in Primary Biliary Cholangitis
por: Chen, Qubo, et al.
Publicado: (2020)

CD38 Defines a Subset of B Cells in Rainbow Trout Kidney With High IgM Secreting Capacities
por: Martín, Diana, et al.
Publicado: (2021)

Loss of Anergic B Cells in Prediabetic and New-Onset Type 1 Diabetic Patients
por: Smith, Mia J., et al.
Publicado: (2015)

Anergic B Cells: Precarious On-Call Warriors at the Nexus of Autoimmunity and False-Flagged Pathogens
por: Rosenspire, Allen J., et al.
Publicado: (2015)

Responses of CD27(+)CD38(+) plasmablasts, and CD24(hi)CD27(hi) and CD24(hi)CD38(hi) regulatory B cells during primary dengue virus 2 infection
por: Lei, Chenshuang, et al.
Publicado: (2021)

Decreased levels of T follicular helper (CD4+CXCR5+) cells and CD27+CD38+ and CD27+CD38− B cells in ankylosing spondylitis patients correlate with markers of inflammation
por: Lejon, Kristina, et al.
Publicado: (2022)

Reduced life span of anergic self-reactive B cells in a double- transgenic model
Publicado: (1994)

Deficit of circulating CD19(+)CD24(hi)CD38(hi) regulatory B cells in severe aplastic anaemia
por: Zaimoku, Yoshitaka, et al.
Publicado: (2020)

Correlation of CD19(+)CD24(hi)CD38(hi) B cells in coronary artery disease with severity of atherosclerosis
por: Liu, Yang, et al.
Publicado: (2020)

Ontogeny, distribution and function of CD38-expressing B lymphocytes in mice
por: Donís-Hernández, Felipe Raúl, et al.
Publicado: (2001)

Crosslinking of CD38 Receptors Triggers Apoptosis of Malignant B Cells
por: Gambles, M. Tommy, et al.
Publicado: (2021)

A B Cell Receptor with Two Igα Cytoplasmic Domains Supports Development of Mature But Anergic B Cells
por: Reichlin, Amy, et al.
Publicado: (2004)

CD19(+) CD24(hi) CD38(hi) Regulatory B Cells and Memory B Cells in Periodontitis: Association with Pro-Inflammatory and Anti-Inflammatory Cytokines
por: Hetta, Helal F., et al.
Publicado: (2020)

Heterogeneity of CD34 and CD38 expression in acute B lymphoblastic leukemia cells is reversible and not hierarchically organized
por: Jiang, Zhiwu, et al.
Publicado: (2016)

CD27(hi)CD38(hi) plasmablasts are activated B cells of mixed origin with distinct function
por: Rouers, Angeline, et al.
Publicado: (2021)

Circulating anergic B cells in the periphery of active systemic lupus erythematosus patients: functional and phenotypic characterization
por: Grammer, A, et al.
Publicado: (2003)

Anti‐TNF treatment negatively regulates human CD4(+) T‐cell activation and maturation in vitro, but does not confer an anergic or suppressive phenotype
por: Povoleri, Giovanni A. M., et al.
Publicado: (2019)

CD4+ T Cell Regulatory Network Underlies the Decrease in Th1 and the Increase in Anergic and Th17 Subsets in Severe COVID-19
por: Martinez-Sánchez, Mariana Esther, et al.
Publicado: (2022)

Potential efficacy of dopaminergic antidepressants in treatment resistant anergic-anhedonic depression results of the chronic anergic-anhedonic depression open trial – CADOT
por: Dormegny-Jeanjean, Ludovic Christophe, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t412cnl7t5613r93c0b9n97631